Research and Development

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …

Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).

Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition …

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …

Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …

Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …

This training will offer you the overview of the existing regulatory aspects of the CMC, and will also give you …

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …